Skip to main content
Top
Published in: BMC Neurology 1/2024

Open Access 01-12-2024 | Encephalopathy | Case Report

Frontal deficits and atrophy in a patient with familial encephalopathy with neuroserpin inclusion bodies detected by single-case voxel-based morphometry: a case report

Authors: Hideo Handa, Atsuhiko Sugiyama, Tadashi Kaname, Yoko Shigemoto, Noriko Sato, Shigeki Hirano, Yuki Nakagawa, Akiyuki Uzawa, Akiyo Aotsuka, Satoshi Kuwabara

Published in: BMC Neurology | Issue 1/2024

Login to get access

Abstract

Background

Familial encephalopathy with neuroserpin inclusion bodies (FENIB) is a rare genetic disorder characterized by progressive cognitive decline and myoclonic epilepsy, caused by pathogenic variants of SERPINI1. We reported a case of genetically confirmed FENIB with de novo H338R mutation in the SERPINI1, in which frontal deficits including inattention and disinhibition, and relevant atrophy in the vmPFC on brain MRI were observed in the early stage of the disease.

Case presentation

A 23-year-old Japanese man presented with progressive inattention and disinhibition over 4 years followed by myoclonic epilepsy. The whole-genome sequencing and filtering analysis showed de novo heterozygous H338R mutation in the SERPINI1, confirming the diagnosis of FENIB. Single-case voxel-based morphometry using brain magnetic resonance imaging obtained at the initial visit revealed focal gray matter volume loss in the ventromedial prefrontal cortices, which is presumed to be associated with inattention and disinhibition.

Conclusion

Frontal deficits including inattention and disinhibition can be the presenting symptoms of patients with FENIB. Single-case voxel-based morphometry may be useful for detecting regional atrophy of the frontal lobe in FENIB. Detecting these abnormalities in the early stage of disease may be key findings for differentiating FENIB from other causes of progressive myoclonic epilepsy.
Literature
1.
go back to reference Godinez A, Rajput R, Chitranshi N, et al. Neuroserpin, a crucial regulator for axogenesis, synaptic modelling and cell-cell interactions in the pathophysiology of neurological Disease. Cell Mol Life Sci. 2022;79:172.CrossRefPubMedPubMedCentral Godinez A, Rajput R, Chitranshi N, et al. Neuroserpin, a crucial regulator for axogenesis, synaptic modelling and cell-cell interactions in the pathophysiology of neurological Disease. Cell Mol Life Sci. 2022;79:172.CrossRefPubMedPubMedCentral
2.
go back to reference Bradshaw CB, Davis RL, Shrimpton AE, et al. Cognitive deficits associated with a recently reported familial neurodegenerative Disease: familial encephalopathy with neuroserpin inclusion bodies. Arch Neurol. 2001;58:1429–34.CrossRefPubMed Bradshaw CB, Davis RL, Shrimpton AE, et al. Cognitive deficits associated with a recently reported familial neurodegenerative Disease: familial encephalopathy with neuroserpin inclusion bodies. Arch Neurol. 2001;58:1429–34.CrossRefPubMed
3.
go back to reference Miranda E, MacLeod I, Davies MJ, et al. The intracellular accumulation of polymeric neuroserpin explains the severity of the Dementia FENIB. Hum Mol Genet. 2008;17:1527–39.CrossRefPubMedPubMedCentral Miranda E, MacLeod I, Davies MJ, et al. The intracellular accumulation of polymeric neuroserpin explains the severity of the Dementia FENIB. Hum Mol Genet. 2008;17:1527–39.CrossRefPubMedPubMedCentral
4.
go back to reference Davis RL, Shrimpton AE, Carrell RW, et al. Association between conformational mutations in neuroserpin and onset and severity of Dementia. Lancet. 2002;359:2242–7.CrossRefPubMed Davis RL, Shrimpton AE, Carrell RW, et al. Association between conformational mutations in neuroserpin and onset and severity of Dementia. Lancet. 2002;359:2242–7.CrossRefPubMed
5.
go back to reference Gourfinkel-An I, Duyckaerts C, Camuzat A, et al. Clinical and neuropathologic study of a French family with a mutation in the neuroserpin gene. Neurology. 2007;69:79–83.CrossRefPubMed Gourfinkel-An I, Duyckaerts C, Camuzat A, et al. Clinical and neuropathologic study of a French family with a mutation in the neuroserpin gene. Neurology. 2007;69:79–83.CrossRefPubMed
6.
go back to reference Takao M, Benson MD, Murrell JR, et al. Neuroserpin mutation S52R causes neuroserpin accumulation in neurons and is associated with Progressive myoclonus Epilepsy. J Neuropathol Exp Neurol. 2000;59:1070–86.CrossRefPubMed Takao M, Benson MD, Murrell JR, et al. Neuroserpin mutation S52R causes neuroserpin accumulation in neurons and is associated with Progressive myoclonus Epilepsy. J Neuropathol Exp Neurol. 2000;59:1070–86.CrossRefPubMed
7.
go back to reference Amano-Takeshige H, Oyama G, Kanai K, et al. A Japanese family with mutation in the proteinase inhibitor 12 L47P gene: a case report. J Neurol Sci. 2018;384:126–8.CrossRefPubMed Amano-Takeshige H, Oyama G, Kanai K, et al. A Japanese family with mutation in the proteinase inhibitor 12 L47P gene: a case report. J Neurol Sci. 2018;384:126–8.CrossRefPubMed
8.
go back to reference Hagen MC, Murrell JR, Delisle MB, et al. Encephalopathy with neuroserpin inclusion bodies presenting as Progressive myoclonus Epilepsy and associated with a novel mutation in the proteinase inhibitor 12 gene. Brain Pathol. 2011;21:575–82.CrossRefPubMedPubMedCentral Hagen MC, Murrell JR, Delisle MB, et al. Encephalopathy with neuroserpin inclusion bodies presenting as Progressive myoclonus Epilepsy and associated with a novel mutation in the proteinase inhibitor 12 gene. Brain Pathol. 2011;21:575–82.CrossRefPubMedPubMedCentral
9.
go back to reference Yang X, Fang Z, Yan L, et al. Role of SERPINI1 pathogenic variants in familial encephalopathy with neuroserpin inclusion bodies: a case report and literature review. Seizure. 2022;103:137–47.CrossRefPubMed Yang X, Fang Z, Yan L, et al. Role of SERPINI1 pathogenic variants in familial encephalopathy with neuroserpin inclusion bodies: a case report and literature review. Seizure. 2022;103:137–47.CrossRefPubMed
10.
go back to reference Kara B, Sarıkaya CE, Bayrak YE, et al. Early-onset rapidly Progressive myoclonic Epilepsy associated with G392R likely pathogenic variant in SERPINI1. Seizure. 2020;80:181–2.CrossRefPubMed Kara B, Sarıkaya CE, Bayrak YE, et al. Early-onset rapidly Progressive myoclonic Epilepsy associated with G392R likely pathogenic variant in SERPINI1. Seizure. 2020;80:181–2.CrossRefPubMed
11.
go back to reference Ranza E, Garcia-Tarodo S, Varvagiannis K, et al. SERPINI1 pathogenic variants: an emerging cause of childhood-onset Progressive myoclonic Epilepsy. Am J Med Genet A. 2017;173:2456–60.CrossRefPubMed Ranza E, Garcia-Tarodo S, Varvagiannis K, et al. SERPINI1 pathogenic variants: an emerging cause of childhood-onset Progressive myoclonic Epilepsy. Am J Med Genet A. 2017;173:2456–60.CrossRefPubMed
12.
go back to reference Hirata Y, Matsuda H, Nemoto K, et al. Voxel-based morphometry to discriminate early Alzheimer’s Disease from controls. Neurosci Lett. 2005;382:269–74.CrossRefPubMed Hirata Y, Matsuda H, Nemoto K, et al. Voxel-based morphometry to discriminate early Alzheimer’s Disease from controls. Neurosci Lett. 2005;382:269–74.CrossRefPubMed
13.
go back to reference Shigemoto Y, Sato N, Maikusa N, et al. Age and sex-related effects on single-subject gray matter networks in healthy participants. J Pers Med. 2023;13:419.CrossRefPubMedPubMedCentral Shigemoto Y, Sato N, Maikusa N, et al. Age and sex-related effects on single-subject gray matter networks in healthy participants. J Pers Med. 2023;13:419.CrossRefPubMedPubMedCentral
14.
go back to reference Orsini A, Valetto A, Bertini V, et al. The best evidence for Progressive myoclonic Epilepsy: a pathway to precision therapy. Seizure. 2019;71:247–57.CrossRefPubMedPubMedCentral Orsini A, Valetto A, Bertini V, et al. The best evidence for Progressive myoclonic Epilepsy: a pathway to precision therapy. Seizure. 2019;71:247–57.CrossRefPubMedPubMedCentral
15.
go back to reference Migliaccio R, Agosta F, Rascovsky K, et al. Clinical syndromes associated with posterior atrophy: early age at onset AD spectrum. Neurology. 2009;73:1571–8.CrossRefPubMedPubMedCentral Migliaccio R, Agosta F, Rascovsky K, et al. Clinical syndromes associated with posterior atrophy: early age at onset AD spectrum. Neurology. 2009;73:1571–8.CrossRefPubMedPubMedCentral
16.
go back to reference Migliaccio R, Agosta F, Scola E, et al. Ventral and dorsal visual streams in posterior cortical atrophy: a DT MRI study. Neurobiol Aging. 2012;33:2572–84.CrossRefPubMedPubMedCentral Migliaccio R, Agosta F, Scola E, et al. Ventral and dorsal visual streams in posterior cortical atrophy: a DT MRI study. Neurobiol Aging. 2012;33:2572–84.CrossRefPubMedPubMedCentral
17.
go back to reference Franke K, Ziegler G, Klöppel S, Gaser C, Alzheimer’s Disease Neuroimaging Initiative. Estimating the age of healthy subjects from T1-weighted MRI scans using kernel methods: exploring the influence of various parameters. NeuroImage. 2010;50:883–92.CrossRefPubMed Franke K, Ziegler G, Klöppel S, Gaser C, Alzheimer’s Disease Neuroimaging Initiative. Estimating the age of healthy subjects from T1-weighted MRI scans using kernel methods: exploring the influence of various parameters. NeuroImage. 2010;50:883–92.CrossRefPubMed
18.
go back to reference Beheshti I, Maikusa N, Matsuda H. The association between brain-age score (BAS) and traditional neuropsychological screening tools in Alzheimer’s Disease. Brain Behav. 2018;8:e01020.CrossRefPubMedPubMedCentral Beheshti I, Maikusa N, Matsuda H. The association between brain-age score (BAS) and traditional neuropsychological screening tools in Alzheimer’s Disease. Brain Behav. 2018;8:e01020.CrossRefPubMedPubMedCentral
Metadata
Title
Frontal deficits and atrophy in a patient with familial encephalopathy with neuroserpin inclusion bodies detected by single-case voxel-based morphometry: a case report
Authors
Hideo Handa
Atsuhiko Sugiyama
Tadashi Kaname
Yoko Shigemoto
Noriko Sato
Shigeki Hirano
Yuki Nakagawa
Akiyuki Uzawa
Akiyo Aotsuka
Satoshi Kuwabara
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2024
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-023-03511-0

Other articles of this Issue 1/2024

BMC Neurology 1/2024 Go to the issue